ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

NCT00004926 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DIETARY_SUPPLEMENT: vitamin D3 analogue ILX23-7553

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]